Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Siemens hears sweet music with €2.15bn deal for Audiology; sees Dx profit jump for Q4

This article was originally published in Clinica

Executive Summary

Money speaks volumes and when Siemens was offered a tidy sum for its successful hearing aids business, it could not turn a deaf ear. Previously-announced plans to spin out Siemens Audiology Solutions as a standalone publicly-listed company have been ditched and instead, the German group has signed a deal to sell the division to investment company EQT and Germany’s Strüngmann family of entrepreneurs as co-investor for €2.15bn ($2.67bn), plus future earn-outs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel